Use my Search Websuite to scan PubMed, PMCentral, Journal Hosts and Journal Archives, FullText. Kick-your-searchterm to multiple Engines kick-your-query now !>

A dictionary by aggregated review articles of nephrology, medicine and the life sciences Your one-stop-run pathway from word to the immediate pdf of peer-reviewed on-topic knowledge.

10.1038/ejcn.2014.251 http://scihub22266oqcxt.onion/10.1038/ejcn.2014.251 C4458894!4458894 !25406966     free     free     free Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 209.6 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Deprecated: Implicit conversion from float 243.2 to int loses precision in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 534 Warning: imagejpeg(C:\Inetpub\vhosts\kidney.de\httpdocs\phplern\25406966 .jpg): Failed to open stream: No such file or directory in C:\Inetpub\vhosts\kidney.de\httpdocs\pget.php on line 117       Eur+J+Clin+Nutr 2015 ; 69 (6 ): 707-11 Nephropedia Template TP {{tp|p=25406966 |t=2015. Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial |pdf=|usr=}}{{25406966 }} gab.com Text Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial JO: Eur J Clin Nutr http://www.kidney.de/pget.php?&tw=1&pmid=25406966 #FOAvip OBJECTIVES: To study the effect of Vitamin D3 supplementation on metabolic control in an obese type 2 diabetes Emirati population. METHODS: This randomized double-blind clinical trial was conducted with 87 vitamin D-deficient obese, type 2 diabetic participants. The vitamin D-group (n=45) and the placebo group (n=42) were matched for gender, age, HbA1c and 25-hydroxy vitamin D (25(OH) D) at the baseline. The study was divided into two phases of 3 months each; in phase 1, the vitamin D-group received 6000?IU vitamin D3/day followed by 3000?IU vitamin D3/day in phase 2, whereas the placebo group (n=42) received matching placebo. RESULTS: After supplementation, serum 25(OH) D peaked in the vitamin D-group in phase 1 (77.2±30.1?nmol/l, P=0.003) followed by a decrease in the phase 2 (61.4±18.8?nmol/l, P=0.006), although this was higher compared with baseline. In the placebo group, no difference was observed in the serum 25(OH) D levels throughout the intervention. Relative to baseline serum, parathyroid hormone decreased 24% (P=0.003) in the vitamin D-group in phase 2, but remained unchanged in the placebo group. No significant changes were observed in blood pressure, fasting blood glucose, HbA1c, C-peptide, creatinine, phosphorous, alkaline phosphatase, lipids, C-reactive protein or thyroid stimulating hormone concentrations compared with baseline in either group. CONCLUSIONS: Six months of vitamin D3 supplementation to vitamin D-deficient obese type 2 diabetes patients in the UAE normalized the vitamin D status and reduced the incidence of eucalcemic parathyroid hormone elevation but showed no effect on the metabolic control. Twit Text FOAVip Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial ????Eur J Clin Nutr http://www.kidney.de/pget.php?&tw=1&pmid=25406966 #FOAvip Twit Text # Free Paper on # # # # # LINK http://www.kidney.de/pget.php?&tw=1&pmid=25406966 #FOAvip English Wikipedia <ref>{{Cite pmid|25406966 }}</ref> Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, UAE: a randomized controlled double-blinded clinical trial #MMPMID25406966 Sadiya A ; Ahmed SM ; Carlsson M ; Tesfa Y ; George M ; Ali SH ; Siddieg HH ; Abusnana S Eur J Clin Nutr 2015[Jun]; 69 (6 ): 707-11 PMID25406966 show ga OBJECTIVES: To study the effect of Vitamin D3 supplementation on metabolic control in an obese type 2 diabetes Emirati population. METHODS: This randomized double-blind clinical trial was conducted with 87 vitamin D-deficient obese, type 2 diabetic participants. The vitamin D-group (n=45) and the placebo group (n=42) were matched for gender, age, HbA1c and 25-hydroxy vitamin D (25(OH) D) at the baseline. The study was divided into two phases of 3 months each; in phase 1, the vitamin D-group received 6000?IU vitamin D3/day followed by 3000?IU vitamin D3/day in phase 2, whereas the placebo group (n=42) received matching placebo. RESULTS: After supplementation, serum 25(OH) D peaked in the vitamin D-group in phase 1 (77.2±30.1?nmol/l, P=0.003) followed by a decrease in the phase 2 (61.4±18.8?nmol/l, P=0.006), although this was higher compared with baseline. In the placebo group, no difference was observed in the serum 25(OH) D levels throughout the intervention. Relative to baseline serum, parathyroid hormone decreased 24% (P=0.003) in the vitamin D-group in phase 2, but remained unchanged in the placebo group. No significant changes were observed in blood pressure, fasting blood glucose, HbA1c, C-peptide, creatinine, phosphorous, alkaline phosphatase, lipids, C-reactive protein or thyroid stimulating hormone concentrations compared with baseline in either group. CONCLUSIONS: Six months of vitamin D3 supplementation to vitamin D-deficient obese type 2 diabetes patients in the UAE normalized the vitamin D status and reduced the incidence of eucalcemic parathyroid hormone elevation but showed no effect on the metabolic control. |*Dietary Supplements/adverse effects [MESH] |Adult [MESH] |Body Mass Index [MESH] |Calcifediol/blood [MESH] |Cholecalciferol/administration & dosage/adverse effects/*therapeutic use [MESH] |Diabetes Mellitus, Type 2/*complications [MESH] |Double-Blind Method [MESH] |Female [MESH] |Glycated Hemoglobin/analysis [MESH] |Humans [MESH] |Hyperparathyroidism, Secondary/epidemiology/etiology/*prevention & control [MESH] |Incidence [MESH] |Lost to Follow-Up [MESH] |Male [MESH] |Middle Aged [MESH] |Obesity/*complications [MESH] |Parathyroid Hormone/blood [MESH] |Patient Dropouts [MESH] |United Arab Emirates/epidemiology [MESH]Vitamin D supplementation in obese type 2 diabetes subjects in Ajman, (epmc).pdf DeepDyve Pubget Overpricing